Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Center of Martinique
About this trial
Estimating the prevalence of Helicobacter Pylori infection in newly diagnosed stomach cancers in the West-Indies will help to understand the epidemiology of this cancer, which is over-incident in the West Indies compared to France. In addition, the constitution of a biobank (tumor tissues, healthy tissues and serum) will allow to set up in a second time etiological studies to identify other risk factors in particular in connection with the exposure to environmental pollutants to adapt the prevention measures.
Eligibility criteria
Qualifiers
Patient over 18 years of age, residing for at least 6 months in Martinique, with a primary diagnosis of gastric cancer
Patient having read the information note and having signed the consent to participate in the study
Patient with social security coverage
Disqualifiers
Refusal to participate
Patient who could not answer the questionnaires
Patient not affiliated to a social security system
Patient not fluent in French
Trial design
Treatments tested in this trial
- Helicobacter Pylori detection
Treatment groups
112 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov